Acadia Pharma (ACAD) Misses Q4 EPS by 1c; Offers FY23 Revenue Guidance
Go back to Acadia Pharma (ACAD) Misses Q4 EPS by 1c; Offers FY23 Revenue Guidance| Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 26.40 -0.89 (3.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.29 | 52 Week High | $42.49 | |||
| Open | $27.43 | 52 Week Low | $16.64 | |||
| Day High | $27.43 | P/E | N/A | |||
| Day Low | $26.34 | EPS | $-0.42 | |||
| Volume | 1,351,926 | |||||
